Domov › Malobuněčný rakovina plic › Texas › Houston
Klinické štúdie Malobuněčný rakovina plic v meste Houston, TX
26 štúdií pre Malobuněčný rakovina plic hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Prebieha náborFáza 2
- The University of Texas MD Anderson Cancer Center /ID# 277929, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Prebieha náborFáza 2/3
- Texas Oncology - Gulf Coast, Houston
- Texas Oncology - Gulf Coast, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Prebieha náborFáza 3
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Prebieha náborFáza 1/2
- Next Oncology - Houston, Houston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Oncology Consultants, P.A., Houston
- University of Texas M.D. Anderson Cancer Center, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Site 1005, Houston
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, Houston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Prebieha náborFáza 3
- The University of Texas MD Anderson Cancer Center, Houston
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Prebieha náborFáza 1/2
- MD Anderson Cancer Center Uni of Te, Houston
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Prebieha náborFáza 3
- Houston Methodist Cancer Center, Houston
- University of Texas Md Anderson Cancer Center, Houston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
- Oncology Consultants, PA- Houston, Houston
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Prebieha náborFáza 1
- University of Texas MD Anderson Cancer Center, Houston
A Study of LY4175408 in Participants With Advanced Cancer
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Prebieha náborFáza 1/2
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
Prebieha náborFáza 1
- Zelgen Site 106, Houston
Štúdie Malobuněčný rakovina plic v iných mestách
- Arlington, VA23 štúdií
- New York City, NY22 štúdií
- Boston, MA21 štúdií
- Nashville, TN20 štúdií
- Los Angeles, CA20 štúdií
- Orlando, FL15 štúdií
- Dallas, TX13 štúdií
- Cleveland, OH13 štúdií
- Chicago, IL13 štúdií
- St. Louis, MO13 štúdií
- Detroit, MI12 štúdií
- Washington, DC12 štúdií
Iné štúdie v Houston
- Nemalobunkový karcinóm pľúc145 štúdií
- Rakovina prsníka126 štúdií
- Rakovina (všetky typy)121 štúdií
- Metastatická rakovina104 štúdií
- Kolorektálny karcinóm102 štúdií
- Rakovina vaječníkov89 štúdií
- Akútna myeloidná leukémia85 štúdií
- Rakovina pľúc78 štúdií
- Rakovina prostaty76 štúdií
- Rakovina endometria68 štúdií
- Rakovina pankreasu61 štúdií
- Melanóm59 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.